Trial intelligence / Profile preview

Metformin in elderly burn patients

NCT04530058Phase 2Not yet recruiting

Sponsor
Hamilton Health Sciences
Start
Nov 2024
Primary completion
Mar 2028
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of liquid metformin (Aspargo Labs) in burn injury, sponsored by Hamilton Health Sciences. Planned start Nov 2024; status: not yet recruiting.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

burn injury

Beyond the preview

Go deeper on NCT04530058.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04530058.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call